MTHFD2 and cancer: On the purine synthesis side, mechanistic target of rapamycin complex 1 (mTORC1) activation induces purine synthesis in both normal and cancer cells by transcriptional control of MTHFD2, which produces 10-formyl THF, the key folate cofactor in purine synthesis.